RECORDING AND SLIDES: Dr Ty Reidenbaugh discusses GLP-1s, their approved uses, and how they are being studied for treatment of Substance Use Disorders. The webinar recording can be viewed here: https://youtu.be/ZIfKup-gKP0

If you are wanting continuing education credits for viewing this webinar, please email Barbs Schott (bschott@mtpca.org) for instructions.